Cargando…
Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID‐19 in chronic lymphocytic leukaemia?
Infections with SARS‐CoV‐2 have been unduly severe in patients with haematological malignancies, in particular in those with chronic lymphocytic leukaemia (CLL). Based on a series of observations, we propose that an underlying mechanism for the aggressive clinical course of COVID‐19 in CLL is a pauc...
Autores principales: | Smith, Carl Inge Edvard, Zain, Rula, Österborg, Anders, Palma, Marzia, Buggert, Marcus, Bergman, Peter, Bryceson, Yenan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115357/ https://www.ncbi.nlm.nih.gov/pubmed/35244285 http://dx.doi.org/10.1111/sji.13153 |
Ejemplares similares
-
Blastic plasmacytoid dendritic cell neoplasm: a rare lymphoma of extremely aggressive course
por: Żychowska, Magdalena, et al.
Publicado: (2017) -
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
por: Blixt, Lisa, et al.
Publicado: (2021) -
Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
por: Swiecki, Melissa, et al.
Publicado: (2011) -
E-NPP3 controls plasmacytoid dendritic cell numbers in the small intestine
por: Furuta, Yoki, et al.
Publicado: (2017) -
Plasmacytoid Dendritic Cells in Atherosclerosis
por: Döring, Yvonne, et al.
Publicado: (2012)